Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.
Baba TW, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S, Cavacini LA, Posner MR, Katinger H, Stiegler G, Bernacky BJ, Rizvi TA, Schmidt R, Hill LR, Keeling ME, Lu Y, Wright JE, Chou TC, Ruprecht RM. Baba TW, et al. Among authors: ruprecht rm. Nat Med. 2000 Feb;6(2):200-6. doi: 10.1038/72309. Nat Med. 2000. PMID: 10655110
Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine.
Ferrantelli F, Kitabwalla M, Rasmussen RA, Cao C, Chou TC, Katinger H, Stiegler G, Cavacini LA, Bai Y, Cotropia J, Ugen KE, Ruprecht RM. Ferrantelli F, et al. Among authors: ruprecht rm. J Infect Dis. 2004 Jan 1;189(1):71-4. doi: 10.1086/380102. Epub 2003 Dec 31. J Infect Dis. 2004. PMID: 14702155
Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies.
Ferrantelli F, Rasmussen RA, Buckley KA, Li PL, Wang T, Montefiori DC, Katinger H, Stiegler G, Anderson DC, McClure HM, Ruprecht RM. Ferrantelli F, et al. Among authors: ruprecht rm. J Infect Dis. 2004 Jun 15;189(12):2167-73. doi: 10.1086/420833. Epub 2004 May 26. J Infect Dis. 2004. PMID: 15181562
Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques.
Ferrantelli F, Buckley KA, Rasmussen RA, Chalmers A, Wang T, Li PL, Williams AL, Hofmann-Lehmann R, Montefiori DC, Cavacini LA, Katinger H, Stiegler G, Anderson DC, McClure HM, Ruprecht RM. Ferrantelli F, et al. Among authors: ruprecht rm. Virology. 2007 Feb 5;358(1):69-78. doi: 10.1016/j.virol.2006.07.056. Epub 2006 Sep 25. Virology. 2007. PMID: 16996554 Free article.
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins.
Li A, Baba TW, Sodroski J, Zolla-Pazner S, Gorny MK, Robinson J, Posner MR, Katinger H, Barbas CF 3rd, Burton DR, Chou TC, Ruprecht RM. Li A, et al. Among authors: ruprecht rm. AIDS Res Hum Retroviruses. 1997 May 20;13(8):647-56. doi: 10.1089/aid.1997.13.647. AIDS Res Hum Retroviruses. 1997. PMID: 9168233
Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins.
Li A, Katinger H, Posner MR, Cavacini L, Zolla-Pazner S, Gorny MK, Sodroski J, Chou TC, Baba TW, Ruprecht RM. Li A, et al. Among authors: ruprecht rm. J Virol. 1998 Apr;72(4):3235-40. doi: 10.1128/JVI.72.4.3235-3240.1998. J Virol. 1998. PMID: 9525650 Free PMC article.
Oral SIV, SHIV, and HIV type 1 infection.
Ruprecht RM, Baba TW, Liska V, Ayehunie S, Andersen J, Montefiori DC, Trichel A, Murphey-Corb M, Martin L, Rizvi TA, Bernacky BJ, Buchl SJ, Keeling M. Ruprecht RM, et al. AIDS Res Hum Retroviruses. 1998 Apr;14 Suppl 1:S97-103. AIDS Res Hum Retroviruses. 1998. PMID: 9581893
205 results